
Cigna (CI) Stock Forecast & Price Target
Cigna (CI) Analyst Ratings
Bulls say
Cigna Group is a global health services company that specializes in integrated health services such as medical, dental, behavioral health, pharmacy, vision, and supplemental benefits. The company has shown strong performance in its pharmacy benefits management and specialty pharmacy services, driven by key contracts and partnerships. Its strategic initiatives, such as the successful implementation of its rebate-free PBM model and the adoption of its Evernorth platform, have also contributed to its solid financials. The company's diversified revenue mix and focus on sustainable development also make it an attractive investment prospect.
Bears say
Cigna Group is facing several risks, including potential difficulties with accurately pricing and managing healthcare costs, margin erosion in its PBM business as it transitions to a rebate-free model, and potential client losses for its PBM segment. While the company's price-to-earnings ratio is currently at the lower end of its historical range, we believe it is justified given its efforts to address these risks and the company's commitment to diversity and gender parity. Additionally, its use of AI technology to predict and manage healthcare costs may provide cost savings for its customers in the long run.
This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.
Cigna (CI) Analyst Forecast & Price Prediction
Start investing in Cigna (CI)
Order type
Buy in
Order amount
Est. shares
0 shares